Skip to main content
Client Work

LSK Technologies Inc. acquired by Nicoya Lifesciences Inc.

Reading Time 1 minute read Subscribe



LSK Technologies Inc.

On May 2, 2022, Nicoya Lifesciences ("Nicoya"), a global innovator of digital proteomics solutions for diagnostics and biotherapeutic discovery, announced the acquisition of LSK Technologies Inc. ("LSK"), a University of Toronto startup decentralizing laboratory testing with their "lab-in-a-box" platform. LSK's technology enables nucleic acid and protein testing of versatile samples at any time, generating results in 30 minutes while providing real time access to laboratory-grade results.

Fasken advised LSK in connection with its sale to Nicoya with a team comprised of Will Shaw, Ryan Schnier and Laura Fetter.


  • Ontario


    Receive email updates from our team